Mereo BioPharma Group PLC (MREO)
2.62
+0.12
(+4.80%)
USD |
NASDAQ |
Mar 14, 16:00
2.625
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Enterprise Value: 331.51M for March 14, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Verona Pharma PLC | 4.937B |
| TC BioPharm (Holdings) PLC | -0.3828M |
| Autolus Therapeutics PLC | -159.42M |
| Biodexa Pharmaceuticals PLC | -4.640M |
| Bicycle Therapeutics PLC | -211.72M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.00M |
| Total Expenses (Quarterly) | 9.147M |
| EPS Diluted (Quarterly) | -0.10 |
| Earnings Yield | -11.45% |